Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080168 · ClinicalTrials.gov registry record
The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 220
- Enrollment target
NCT03080168: Completed study, sponsored by VA Office of Research and Development.
NCT03080168 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03080168 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
This is a research project looking at whether measuring movements or responses to certain questions can help predict suicidal thoughts or actions. This project has two parts: The first part will occur while the participant is receiving hospitalized at the Bedford VA Hospital. It involves wearing a watch-like device on his/her wrist and answering questions or doing tasks to measure mood and other mental health symptoms, and suicidal thoughts. In the second phase, the investigators will call the participant around 12 months after s/he has left the hospital. The investigators will discuss how s/he is doing and if s/he has had suicidal thoughts or made suicidal acts.
Interventions
- DEVICE Actigraph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2021-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03080168
The ClinicalTrials.gov registry entry for NCT03080168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Actigraph is the first listed.
NCT03080168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03080168 about?
NCT03080168 is a clinical study titled "The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety". This is a research project looking at whether measuring movements or responses to certain questions can help predict suicidal thoughts or actions. This project has two parts: The first part will occur while the participant is receiving hospitalized at the Bedford VA Hospital. It involves wearing a ...
What is the current status of trial NCT03080168?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2017-02-21. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT03080168?
The interventions under investigation include: Actigraph (DEVICE).
Who is sponsoring clinical trial NCT03080168?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.